2010
DOI: 10.1007/s00436-010-2071-z
|View full text |Cite
|
Sign up to set email alerts
|

What is the evidence for the existence of Plasmodium ovale hypnozoites?

Abstract: Relapsing human malaria is regarded to be caused by Plasmodium vivax and Plasmodium ovale. P. vivax relapses originate from dormant liver stages: "hypnozoites". Also, P. ovale, a species considered as closely related to P. vivax, is in analogy assumed to display hypnozoites. A close biologic relationship is, however, not supported by molecular genetic studies. Therefore, original literature published since the description of P. ovale in 1922 was systematically screened for the demonstration of hypnozoites or c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
44
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 64 publications
(45 citation statements)
references
References 41 publications
1
44
0
Order By: Relevance
“…The present case of a malaria recurrence due to P. malariae adds to other similar cases published elsewhere, in which quartan malaria occurred in spite of previous antimalarial medication after a delay between 17 days and 14 weeks (Hess et al 1993;Grobusch et al 2004;Müller-Stöver et al 2008). Recurrent malaria attacks even years after last exposure have been described in Plasmodium vivax, Plasmodium ovale, P. falciparum and P. malariae infections (Shute 1946;Trager and Most 1963;Giobbia et al 2005;Greenwood et al 2008, Focá et al 2009Szmitko et al 2009;Theunissen et al 2009;White 2009;Markus 2011a, b;Richter et al 2010;White 2011). In P. vivax infection, these recurrences are due to the activation of dormant liver development stages called "hypnozoites" (Krotoski et al 1980;1986;White 2011).…”
supporting
confidence: 66%
See 1 more Smart Citation
“…The present case of a malaria recurrence due to P. malariae adds to other similar cases published elsewhere, in which quartan malaria occurred in spite of previous antimalarial medication after a delay between 17 days and 14 weeks (Hess et al 1993;Grobusch et al 2004;Müller-Stöver et al 2008). Recurrent malaria attacks even years after last exposure have been described in Plasmodium vivax, Plasmodium ovale, P. falciparum and P. malariae infections (Shute 1946;Trager and Most 1963;Giobbia et al 2005;Greenwood et al 2008, Focá et al 2009Szmitko et al 2009;Theunissen et al 2009;White 2009;Markus 2011a, b;Richter et al 2010;White 2011). In P. vivax infection, these recurrences are due to the activation of dormant liver development stages called "hypnozoites" (Krotoski et al 1980;1986;White 2011).…”
supporting
confidence: 66%
“…The existence of hypnozoites has been proven for P. vivax, and a number of primate malaria plasmodia (Krotoski et al 1980(Krotoski et al , 1986White 2011). Furthermore, hypnozoites have been assumed to occur in P. ovale infection (White 2009;Richter et al 2010). Malaria recurrences arising from hypnozoites are called relapses.…”
mentioning
confidence: 99%
“…Malaria remains a serious health problem in many parts of the world (Franken et al 2012;Richter et al 2010;Jensen and Mehlhorn 2009). Plasmodium vivax is causing increasingly more cases of severe malaria worldwide (Saxena et al 2012;Tanwar et al 2011;Kochar et al 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Malaria remains a serious health problem in many parts of the world (Jensen and Mehlhorn 2009;Elsheikha and Sheashaa 2007;Richter et al 2010). Plasmodium vivax malaria (PV) has the greatest geographic range and burden of disease.…”
Section: Introductionmentioning
confidence: 99%
“…PV-associated AKI is observed in 2-45% (Kochar et al 2005;Prakash et al 2003). In addition PV is known to cause relapsing human malaria (Richter et al 2010). Even where reliable microscopic diagnosis confirms only PV, PF might still be presumed and its adherent properties might be cited as the basis of its apparent absence in peripheral blood film (PBF).…”
Section: Introductionmentioning
confidence: 99%